CN104491436A - 一种用于坐骨神经痛术后愈合的中药敷药及制备方法 - Google Patents
一种用于坐骨神经痛术后愈合的中药敷药及制备方法 Download PDFInfo
- Publication number
- CN104491436A CN104491436A CN201410772565.1A CN201410772565A CN104491436A CN 104491436 A CN104491436 A CN 104491436A CN 201410772565 A CN201410772565 A CN 201410772565A CN 104491436 A CN104491436 A CN 104491436A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- radix
- sciatica
- portions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 60
- 238000011084 recovery Methods 0.000 title claims abstract description 19
- 208000008765 Sciatica Diseases 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 239000004615 ingredient Substances 0.000 claims abstract description 16
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 claims abstract description 11
- 229940079593 drug Drugs 0.000 claims description 40
- 230000000699 topical effect Effects 0.000 claims description 37
- 241001164374 Calyx Species 0.000 claims description 16
- 241000393548 Candidae Species 0.000 claims description 16
- 241000721156 Chloranthus spicatus Species 0.000 claims description 16
- 241000628997 Flos Species 0.000 claims description 16
- 241000594394 Hedyotis Species 0.000 claims description 16
- 239000000284 extract Substances 0.000 claims description 16
- 239000000843 powder Substances 0.000 claims description 15
- 229940040145 liniment Drugs 0.000 claims description 13
- 239000000865 liniment Substances 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000012153 distilled water Substances 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 239000002994 raw material Substances 0.000 claims description 12
- 241000563984 Ampelopsis Species 0.000 claims description 10
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 9
- 235000008216 herbs Nutrition 0.000 claims description 8
- 241000727553 Ampelopsis delavayana Species 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 238000012545 processing Methods 0.000 claims description 6
- 235000011158 Prunus mume Nutrition 0.000 claims description 3
- 244000018795 Prunus mume Species 0.000 claims description 3
- 230000001476 alcoholic effect Effects 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 208000002193 Pain Diseases 0.000 abstract description 31
- 230000036407 pain Effects 0.000 abstract description 28
- 239000008280 blood Substances 0.000 abstract description 26
- 210000004369 blood Anatomy 0.000 abstract description 26
- 208000027418 Wounds and injury Diseases 0.000 abstract description 24
- 230000008961 swelling Effects 0.000 abstract description 21
- 208000033809 Suppuration Diseases 0.000 abstract description 10
- 241000411851 herbal medicine Species 0.000 abstract description 9
- 206010061218 Inflammation Diseases 0.000 abstract description 6
- 206010052428 Wound Diseases 0.000 abstract description 6
- 238000001816 cooling Methods 0.000 abstract description 6
- 230000035876 healing Effects 0.000 abstract description 5
- 206010048038 Wound infection Diseases 0.000 abstract description 3
- 230000004054 inflammatory process Effects 0.000 abstract description 3
- 230000001954 sterilising effect Effects 0.000 abstract description 3
- 230000000740 bleeding effect Effects 0.000 abstract description 2
- 230000002349 favourable effect Effects 0.000 abstract description 2
- 241000219302 Basella alba Species 0.000 abstract 1
- 235000009380 Basella rubra Nutrition 0.000 abstract 1
- 241000167550 Centella Species 0.000 abstract 1
- 241001310046 Chloranthus serratus Species 0.000 abstract 1
- 241000531321 Colebrookea oppositifolia Species 0.000 abstract 1
- 235000008956 Dioscorea cirrhosa Nutrition 0.000 abstract 1
- 241001648081 Dioscorea cirrhosa Species 0.000 abstract 1
- 241001558017 Gynura Species 0.000 abstract 1
- 244000048199 Hibiscus mutabilis Species 0.000 abstract 1
- 235000003973 Hibiscus mutabilis Nutrition 0.000 abstract 1
- 244000219416 Hypericum japonicum Species 0.000 abstract 1
- 241001412304 Ixeris Species 0.000 abstract 1
- 241001568512 Lysimachia candida Species 0.000 abstract 1
- 241000219099 Parthenocissus quinquefolia Species 0.000 abstract 1
- 244000292697 Polygonum aviculare Species 0.000 abstract 1
- 235000006386 Polygonum aviculare Nutrition 0.000 abstract 1
- 240000005860 Portulaca grandiflora Species 0.000 abstract 1
- 241000733310 Rhaphidophora <angiosperm> Species 0.000 abstract 1
- 230000009194 climbing Effects 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 208000014674 injury Diseases 0.000 description 35
- 230000006378 damage Effects 0.000 description 23
- 231100000614 poison Toxicity 0.000 description 18
- 230000001737 promoting effect Effects 0.000 description 17
- 210000003497 sciatic nerve Anatomy 0.000 description 17
- 230000008736 traumatic injury Effects 0.000 description 17
- 239000003440 toxic substance Substances 0.000 description 16
- 230000017531 blood circulation Effects 0.000 description 11
- 230000023597 hemostasis Effects 0.000 description 11
- 206010017553 Furuncle Diseases 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- 206010007247 Carbuncle Diseases 0.000 description 9
- 230000002980 postoperative effect Effects 0.000 description 9
- 201000004624 Dermatitis Diseases 0.000 description 7
- 206010027514 Metrorrhagia Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 239000002435 venom Substances 0.000 description 7
- 231100000611 venom Toxicity 0.000 description 7
- 210000001048 venom Anatomy 0.000 description 7
- 208000010392 Bone Fractures Diseases 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000001848 dysentery Diseases 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 208000006820 Arthralgia Diseases 0.000 description 5
- 206010017076 Fracture Diseases 0.000 description 5
- 208000025747 Rheumatic disease Diseases 0.000 description 5
- 208000010668 atopic eczema Diseases 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 230000000552 rheumatic effect Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 208000005171 Dysmenorrhea Diseases 0.000 description 4
- 206010013935 Dysmenorrhoea Diseases 0.000 description 4
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 210000001217 buttock Anatomy 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 208000001780 epistaxis Diseases 0.000 description 4
- 210000002683 foot Anatomy 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 208000008035 Back Pain Diseases 0.000 description 3
- 208000000616 Hemoptysis Diseases 0.000 description 3
- 208000007514 Herpes zoster Diseases 0.000 description 3
- 208000008930 Low Back Pain Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 206010067868 Skin mass Diseases 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 208000014617 hemorrhoid Diseases 0.000 description 3
- 210000003026 hypopharynx Anatomy 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000001139 anti-pruritic effect Effects 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 201000007772 internal hemorrhoid Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 208000004296 neuralgia Diseases 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 210000004197 pelvis Anatomy 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 201000003068 rheumatic fever Diseases 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 210000004706 scrotum Anatomy 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010002953 Aphonia Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010021531 Impetigo Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010023204 Joint dislocation Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 208000007027 Oral Candidiasis Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
- 208000010886 Peripheral nerve injury Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 206010039670 Sciatic nerve injury Diseases 0.000 description 1
- 206010040026 Sensory disturbance Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- 241000287411 Turdidae Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 210000000544 articulatio talocruralis Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000005021 gait Effects 0.000 description 1
- 230000035929 gnawing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 238000002639 hyperbaric oxygen therapy Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 230000007659 motor function Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 210000003314 quadriceps muscle Anatomy 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000003371 toe Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 238000012876 topography Methods 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用于坐骨神经痛术后愈合的中药敷药及制备方法,属中药领域;本发明敷药有效成分的原料组成为:积雪草、珠兰、芙蓉花、落葵、单条草、羽萼、半春莲、耳草、观音苋、廊茵、金刚散、薯莨、爬树龙、及己、山苦荬和苏木;本发明敷药采用中草药为有效成分,诸药相合具有消炎杀菌、散瘀止痛、排脓消肿、凉血止血等功效,对于用于坐骨神经损伤术后护理具有防治伤口感染、化脓及愈合快、安全方便等优点,有利于术后伤口的愈合,可广泛用于坐骨神经损伤术后护理。
Description
所属技术领域
本发明涉及中药领域,尤其涉及一种用于坐骨神经痛术后愈合的中药敷药及制备方法。
背景技术
坐骨神经由腰4、5和骶1-3神经根组成,为全身最粗大的神经,其起始处直径为15mm左右。经坐骨大孔穿出骨盆,坐骨神经一般自梨状肌下孔穿至臀部,亦有少数情况(36.21%)坐骨神经分成2股,一股穿梨状肌,一股出梨状肌下孔;也有分成多股出骨盆者。
髋关节后脱位、臀部刀伤、臀肌挛缩手术伤以及臀部肌注药物均可致其高位损伤,引起股后部肌肉及小腿和足部所有肌肉全部瘫痪,导致膝关节不能屈、踝关节与足趾运动功能完全丧失,呈足下垂。小腿后外侧和足部感觉丧失,足部出现神经营养性改变。由于股四头肌健全,膝关节呈伸直状态,行走时呈跨越步态。如在股后中、下部损伤,则股后部肌肉正常,膝关节屈曲功能保存。
臀部坐骨神经损伤是周围神经损伤中最难处理和疗效最差的损伤之一。其各段损伤与局部解剖关系密切。药物注射伤应争取尽早行神经松解术,生理盐水反复冲洗,术后采用高压氧治疗可有效促进损伤坐骨神经再生修复,患者年龄越小,手术越早,效果越好。
随着现代医学的不断发展,术后护理也逐渐得到重视,在进行护理后,对病人患处进行正确的护理对于疾病的恢复将具有重要意义,为此我们需要研制一种药物来帮助手术后的辅助护理。
发明内容
本发明提供了一种用于坐骨神经痛术后愈合的中药敷药及制备方法;本发明敷药采用中草药为有效成分,诸药相合具有消炎杀菌、散瘀止痛、排脓消肿、凉血止血等功效,对于用于坐骨神经损伤术后护理具有防治伤口感染、化脓及愈合快、安全方便等优点,有利于术后伤口的愈合,可广泛用于坐骨神经损伤术后护理。
为实现上述目的,本发明的技术方案实施如下:
一种用于坐骨神经痛术后愈合的中药敷药,制成所述敷药有效成分的原料组成及重量份数为:
积雪草32-64份 珠兰30-62份 芙蓉花28-60份 落葵26-58份
单条草26-58份 羽萼25-57份 半春莲24-48份 耳草22-46份
观音苋20-44份 廊茵18-42份 金刚散16-40份 薯莨15-39份
爬树龙14-34份 及己12-32份 山苦荬12-32份 苏木10-30份。
制成所述敷药有效成分的原料组成及重量份数为:
积雪草56份 珠兰54份 芙蓉花52份 落葵50份
单条草50份 羽萼49份 半春莲42份 耳草40份
观音苋38份 廊茵36份 金刚散34份 薯莨33份
爬树龙29份 及己27份 山苦荬27份 苏木25份。
制成所述敷药有效成分的原料组成及重量份数为:
积雪草48份 珠兰46份 芙蓉花44份 落葵42份
单条草42份 羽萼41份 半春莲36份 耳草34份
观音苋32份 廊茵30份 金刚散28份 薯莨27份
爬树龙24份 及己22份 山苦荬22份 苏木20份。
制成所述敷药有效成分的原料组成及重量份数为:
积雪草40份 珠兰38份 芙蓉花36份 落葵34份
单条草34份 羽萼33份 半春莲30份 耳草28份
观音苋26份 廊茵24份 金刚散22份 薯莨21份
爬树龙19份 及己17份 山苦荬17份 苏木15份。
一种用于坐骨神经痛术后愈合的中药敷药的制备方法,包括以下工艺步骤:
(1)将积雪草、落葵、观音苋、廊茵、金刚散和薯莨绞汁,滤杂质,留汁液,备用;
(2)将珠兰、芙蓉花、羽萼、爬树龙和山苦荬研末,过180目细粉,备用;
(3)将单条草、半春莲、耳草和及己放入容器中,加入蒸馏水煮沸提取3次,首次加10-15倍量蒸馏水浸泡4-5小时,加热煮沸3-4小时,提取;第二次加8-10倍量蒸馏水加热煮沸2-3小时,提取;第三次加6-8倍量蒸馏水加热煮沸1-2小时,提取;合并三次提取液,滤过,得滤液,浓缩成干浸膏备用;将干浸膏加入体积浓度为90%酒精溶液,静置,将上清液抽取出,沉淀下来的浸膏备用;
(4)将苏木去上粗皮并节了细锉了,重捣,拌细条梅枝蒸,从已至申,出,阴干,研末,过200目细粉,备用;
(5)将步骤(1)制得的汁液、步骤(2)和步骤(4)制得的细粉以及步骤(3)制得的浸膏混合,制成敷药,即为本发明所述的用于坐骨神经痛术后愈合的中药敷药。
本发明所用中药的药性如下:
积雪草:味苦、辛、性寒;归肺、脾、肾、膀胱经。清热利湿,活血止血,解毒消肿。主发热,咳喘,咽喉肿痛,肠为为,痢疾,湿热黄疸,水肿,淋证,尿血,衄血,痛经,崩漏,丹毒,瘰疬,亲疮肿毒,带状疱疹,跌打肿痛,外伤出血,蛇虫咬伤。《日华子本草》载:“以盐挪贴,消肿毒并风疹疥癣。”现代医学研究证实,幼芽的水提取物有抗菌作用。
珠兰:味辛、温,性甘;归肝经。祛风定,活血止痛,杀虫。主风湿痹痛,跌打损伤,偏头痛,顽癣。《陆川本草》载:“破积,止痛,止血。治跌打损伤,刀伤出血。”
芙蓉花:味辛,微苦,性凉;归肺、心、肝经。清热解毒,凉血止血,消肿排脓。主肺热咳嗽,吐血,目赤肿痛,崩漏,白带,腹泻,腹痛,痈肿,疮疖,毒蛇咬伤,水火烫伤,跌打损伤。
落葵:味甘、酸,性寒。滑肠通便,清热利湿,凉血解毒,活血。主大便秘结,小便短涩,痢疾,热毒疮疡,跌打损伤。《陆川本草》载:“凉血,解毒,消炎,生肌。治热毒,火疮,血瘙,斑疹。”现代医学研究证实,落葵具有抗炎作用。
单条草:味苦,性凉;归脾、肾经。清热解毒,活血止痛,利温消肿。主咽喉肿痛,痈肿疮毒,乳痈,毒蛇咬伤,跌打骨折,风湿痹痛,脚气水。《广西药植名录》载:“治痈疮,无名肿毒。”
羽萼:味辛,性平。止血,解毒,止痒。主鼻衄,咳血,外伤出血,皮炎,癣症。
半春莲:味凉、苦,性辛;归心、脾经。清热,消肿,解毒。主虚火牙痛,鹅口疮,无名肿毒,毒蛇咬伤,跌打损伤,风湿痹痛。
耳草:味苦;性凉。清热解毒,凉血消肿。主感冒发热,肺热咳嗽,咽喉肿痛,肠炎,痢疾,痔疮出血,崩漏,毒蛇咬伤,乳腺炎,痈疖肿毒,湿疹,跌打损伤。
观音苋:味辛、甘,性凉。清热凉血,解毒消。主咳血,崩漏,外伤出血,痛经,痢疾,疮疡肿毒,跌打损伤,溃疡久不收敛。《福建中草药》载:“生血止血,清热消肿。”
廊茵:味苦、酸、微辛,性平。清热解毒,和湿止痒,散瘀消肿。主痈疮疔疖,毒蛇咬伤,湿疹,黄水疮,带状疱疹,跌打损伤,愉、内痔外痔。江西《草药手册》载:“行血散瘀,消肿解毒。治蛇头疮,顽固性痈疖,婴儿胎毒,蛇咬伤,跌伤,湿疹痒痛,外痔,内痔。”
金刚散:味辛、淡、涩,性平;归心、肝经。清热利湿,活血通络,止血生肌,解毒消肿。主淋证,白浊,疝气,偏坠,风湿痹痛,跌打瘀肿,创伤出血,烫伤,疮痈。《陕西中草药》载:“消肿解毒,止血止痛,排脓生肌,祛风湿。治跌打损伤,骨折,风湿性关节炎,风湿性腰腿痛,便血,崩漏,白带。”
薯莨:味苦、性凉;小毒。活血止血,理气止痛,清热解毒。主咳血,咯血,
呕血,衄血,尿血,便血,崩漏,月经不调,痛经,经闭,产后腹痛,脘腹胀痛,痧胀腹痛,热毒血痢,水泻,关节痛,跌打肿痛,疮疖,带状疱疹,外伤出血。《湖南药物志》载:“活血,补血,止痛,散气。治筋骨痛,关节炎腰痛,内伤吐血。”现代医学研究证实,薯莨提取液似有类似血小板的促凝作用。
爬树龙:味辛,性温。祛风湿,散瘀肿,续筋骨。主风湿关节炎,跌打瘀肿,骨折,烧伤,痈疮红肿。《云南思茅中草药选》载:“接骨消肿,清热解毒,止血止痛,镇咳。”
及己:味苦,性平,有毒;归肝经。活血散瘀,祛风止痛,解毒杀虫。主跌打损伤,骨折,经闭,风湿痹痛,疔疮疖肿,疥癣,皮肤瘙痒,毒蛇咬伤。浙江民间常用草药》载:“散瘀活血,抗菌消炎。治跌伤,扭伤,骨折,疖肿,经闭。”
山苦荬:味苦,性寒。清热解毒,消肿排脓,凉血止血。主肠痈,肺脓疡,肺热咳嗽,肠炎,痢疾疾,胆囊炎,盆腔炎,疮疖肿毒,阴囊湿疹,吐血,衄血,血崩,跌打捞员伤。《陕西中草药》载:“清热解毒,泻肺火,凉血,止血,止痛,调经,活血,化腐生肌。治无名肿毒,阴囊湿疹,肺炎,跌打损伤,骨折。”
苏木:味甘、咸,性平;归心、肝、胃、大肠经。活血祛瘀,消肿定痛。主妇人血滞经闭,痛经,产后瘀阻心腹痛,产后血晕,痈肿,跌打损伤,破伤风。《日华子本草》载:“治妇人血气心腹痛,月候不调及蓐劳。排脓止痛,消痈肿扑损瘀血,女人失音,血噤,赤白痢并后分急痛。”现代医学研究证实,苏木煎液对金黄色葡萄球菌和伤寒杆菌作用较强。
本发明与现有技术相比,具有以下有益效果:
本发明敷药采用中草药为有效成分,诸药相合具有消炎杀菌、散瘀止痛、排脓消肿、凉血止血等功效,对于用于坐骨神经损伤术后护理具有防治伤口感染、化脓及愈合快、安全方便等优点,有利于术后伤口的愈合,可广泛用于坐骨神经损伤术后护理。
具体实施方式
下面结合具体实施例对本发明做进一步阐述。
实施例1
本发明敷药有效成分的原料组成及重量为:
积雪草62g 珠兰60g 芙蓉花59g 落葵57g
单条草57g 羽萼56g 半春莲47g 耳草45g
观音苋42g 廊茵40g 金刚散39g 薯莨38g
爬树龙33g 及己31g 山苦荬31g 苏木29g。
本发明敷药制备方法的工艺步骤为:
(1)将积雪草、落葵、观音苋、廊茵、金刚散和薯莨绞汁,滤杂质,留汁液,备用;
(2)将珠兰、芙蓉花、羽萼、爬树龙和山苦荬研末,过180目细粉,备用;
(3)将单条草、半春莲、耳草和及己放入容器中,加入蒸馏水煮沸提取3次,首次加10-15倍量蒸馏水浸泡4-5小时,加热煮沸3-4小时,提取;第二次加8-10倍量蒸馏水加热煮沸2-3小时,提取;第三次加6-8倍量蒸馏水加热煮沸1-2小时,提取;合并三次提取液,滤过,得滤液,浓缩成干浸膏备用;将干浸膏加入体积浓度为90%酒精溶液,静置,将上清液抽取出,沉淀下来的浸膏备用;
(4)将苏木去上粗皮并节了细锉了,重捣,拌细条梅枝蒸,从已至申,出,阴干,研末,过200目细粉,备用;
(5)将步骤(1)制得的汁液、步骤(2)和步骤(4)制得的细粉以及步骤(3)制得的浸膏混合,制成敷药,即为本发明所述的用于坐骨神经痛术后愈合的中药敷药。
用法用量:在手术结束后,将手术部位用酒精进行消毒,取本发明敷药敷于上方,每12小时更换一次。
实施例2
本发明敷药有效成分的原料组成及重量为:
积雪草56g 珠兰54g 芙蓉花52g 落葵50g
单条草50g 羽萼49g 半春莲42g 耳草40g
观音苋38g 廊茵36g 金刚散34g 薯莨33g
爬树龙29g 及己27g 山苦荬27g 苏木25g。
本实施例的敷药制备方法工艺步骤及用法用量与实施例1相同。
实施例3
本发明敷药有效成分的原料组成及重量为:
积雪草48g 珠兰46g 芙蓉花44g 落葵42g
单条草42g 羽萼41g 半春莲36g 耳草34g
观音苋32g 廊茵30g 金刚散28g 薯莨27g
爬树龙24g 及己22g 山苦荬22g 苏木20g。
本实施例的敷药制备方法工艺步骤及用法用量与实施例1相同。
实施例4
本发明敷药有效成分的原料组成及重量为:
积雪草40g 珠兰38g 芙蓉花36g 落葵34g
单条草34g 羽萼33g 半春莲30g 耳草28g
观音苋26g 廊茵24g 金刚散22g 薯莨21g
爬树龙19g 及己17g 山苦荬17g 苏木15g。
本实施例的敷药制备方法工艺步骤及用法用量与实施例1相同。
临床资料:
1、病例选择:
作为治疗坐骨神经损伤的敷药,选择我院或外院确诊的坐骨神经损伤患者110例临床观察,病人随机分成两组,治疗组55例,其中男性23例,女性22例,年龄20-68岁,平均年龄35岁,病程2个月-6年;对照组55例,其中男性23例,女性22例,年龄25-60岁,平均年龄38岁,病程2个月-5年。两组病例的病程、症状轻重程度基本一致,无显著差异,具有可比性。
2、治疗方法:
治疗组患者进行手术治疗后,取本发明敷药敷于上方,每12小时更换一次。连续使用一个月。
对照组使用骨通贴,按说明书用,病情严重者遵医嘱酌增用量。
3、疗效判定:
(1)治愈:发炎、疼痛、刀口肿胀、排脓等症状消失,身体恢复正常。
(2)有效:上述症状有所缓解。
(3)无效:病症无变化。
4、结果:
敷用本发明敷药的治疗组中,治愈37例,有效13例,无效5例,治愈率为67.2%,总有效率90.9%。
对照组中治愈8例,有效25例,无效22例,治愈率为14.5%,总有效率60%。
以上结果显示,治疗组治愈率和总有效率明显高于对照组。
典型病例举例:
1、冷某,女,56岁,退休干部,黑龙江大庆人。患者出现感觉障碍、步态异常、反射性腰痛等症状被送至我院就诊,检查后确诊为坐骨神经损伤。进行坐骨神经损伤手术后,刀口出现红肿、疼痛等症状,后敷本发明敷药2个疗程后,上述症状减轻;继续敷本发明敷药2个疗程,上述症状消失,随访未复发,彻底治愈。
2、许某,男,42岁,建筑工人,吉林四平人。患者患有坐骨神经损伤史5年余,在当地医院进行手术治疗后,每年皆会有复发,臀部闪电疼痛不止。为进一步诊治,来我院做手术。为巩固治疗敷本发明敷药3个疗程,身体开始好转;继续敷本发明敷药2个疗程,身体痊愈,随访未复发,彻底治愈。
3、曹某,男,38岁,公务员,河北衡水人。患者2年前查出有坐骨神经损伤,在当地医院进行诊治,未有好转,经朋友介绍来我院就诊,实施手术后敷本发明敷药2个疗程,身体状况好转,继续敷本发明敷药2个疗程后,身体痊愈,随访未复发。
4、周某,女,36岁,销售员,山东莱芜人。患者因坐骨神经损伤痛发无数次,每乏力疲劳时就会复发,经地方医生介绍来我院就诊,进行手术后敷本发明敷药1个疗程,疼痛减轻,活动自如;继续敷本发明敷药2个疗程,上述症状全部消失,随访未复发,彻底治愈。
5、黄某,男,25岁,业务员,吉林通化人。患者因出现电击样剧痛的症状被送至我院就诊,通过检查确诊为坐骨神经损伤,实施手术后敷本发明敷药2个疗程,疼痛好转;继续敷本发明敷药2个疗程后,疼痛消失,伤口愈合,身体痊愈,随访未复发。
6、林某,男,23岁,学生,江苏徐州人。患者进行坐骨神经损伤手术后,伤口出现红肿,手术两天后出现排脓、疼痛等症状,并伴有神经痛。后敷本发明敷药1个疗程后,上述症状好转;继续敷本发明敷药1个疗程,上述症状消失,身体痊愈,随访未复发,彻底治愈。
Claims (5)
1.一种用于坐骨神经痛术后愈合的中药敷药,其特征在于:制成所述敷药有效成分的原料组成及重量份数为:
积雪草32-64份 珠兰30-62份 芙蓉花28-60份 落葵26-58份
单条草26-58份 羽萼25-57份 半春莲24-48份 耳草22-46份
观音苋20-44份 廊茵18-42份 金刚散16-40份 薯莨15-39份
爬树龙14-34份 及己12-32份 山苦荬12-32份 苏木10-30份。
2.根据权利要求1所述的一种用于坐骨神经痛术后愈合的中药敷药,其特征在于:制成所述敷药有效成分的原料组成及重量份数为:
积雪草56份 珠兰54份 芙蓉花52份 落葵50份
单条草50份 羽萼49份 半春莲42份 耳草40份
观音苋38份 廊茵36份 金刚散34份 薯莨33份
爬树龙29份 及己27份 山苦荬27份 苏木25份。
3.根据权利要求1所述的一种用于坐骨神经痛术后愈合的中药敷药,其特征在于:制成所述敷药有效成分的原料组成及重量份数为:
积雪草48份 珠兰46份 芙蓉花44份 落葵42份
单条草42份 羽萼41份 半春莲36份 耳草34份
观音苋32份 廊茵30份 金刚散28份 薯莨27份
爬树龙24份 及己22份 山苦荬22份 苏木20份。
4.根据权利要求1所述的一种用于坐骨神经痛术后愈合的中药敷药,其特征在于:制成所述敷药有效成分的原料组成及重量份数为:
积雪草40份 珠兰38份 芙蓉花36份 落葵34份
单条草34份 羽萼33份 半春莲30份 耳草28份
观音苋26份 廊茵24份 金刚散22份 薯莨21份
爬树龙19份 及己17份 山苦荬17份 苏木15份。
5.一种如权利要求1-4所述的用于坐骨神经痛术后愈合的中药敷药的制备方法,其特征在于:包括以下工艺步骤:
(1)将积雪草、落葵、观音苋、廊茵、金刚散和薯莨绞汁,滤杂质,留汁液,备用;
(2)将珠兰、芙蓉花、羽萼、爬树龙和山苦荬研末,过180目细粉,备用;
(3)将单条草、半春莲、耳草和及己放入容器中,加入蒸馏水煮沸提取3次,首次加10-15倍量蒸馏水浸泡4-5小时,加热煮沸3-4小时,提取;第二次加8-10倍量蒸馏水加热煮沸2-3小时,提取;第三次加6-8倍量蒸馏水加热煮沸1-2小时,提取;合并三次提取液,滤过,得滤液,浓缩成干浸膏备用;将干浸膏加入体积浓度为90%酒精溶液,静置,将上清液抽取出,沉淀下来的浸膏备用;
(4)将苏木去上粗皮并节了细锉了,重捣,拌细条梅枝蒸,从已至申,出,阴干,研末,过200目细粉,备用;
(5)将步骤(1)制得的汁液、步骤(2)和步骤(4)制得的细粉以及步骤(3)制得的浸膏混合,制成敷药,即为所述的用于坐骨神经痛术后愈合的中药敷药。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410772565.1A CN104491436A (zh) | 2014-12-12 | 2014-12-12 | 一种用于坐骨神经痛术后愈合的中药敷药及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410772565.1A CN104491436A (zh) | 2014-12-12 | 2014-12-12 | 一种用于坐骨神经痛术后愈合的中药敷药及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104491436A true CN104491436A (zh) | 2015-04-08 |
Family
ID=52932950
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410772565.1A Pending CN104491436A (zh) | 2014-12-12 | 2014-12-12 | 一种用于坐骨神经痛术后愈合的中药敷药及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104491436A (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101085304A (zh) * | 2007-06-18 | 2007-12-12 | 付先进 | 一种主要治疗颈腰椎疾病的膏药 |
CN101279074A (zh) * | 2008-04-10 | 2008-10-08 | 北京中泰天和科技有限公司 | 一种清热利湿、舒筋活络的药物组合及其制备方法 |
-
2014
- 2014-12-12 CN CN201410772565.1A patent/CN104491436A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101085304A (zh) * | 2007-06-18 | 2007-12-12 | 付先进 | 一种主要治疗颈腰椎疾病的膏药 |
CN101279074A (zh) * | 2008-04-10 | 2008-10-08 | 北京中泰天和科技有限公司 | 一种清热利湿、舒筋活络的药物组合及其制备方法 |
Non-Patent Citations (1)
Title |
---|
李国建: "综合治疗腰椎间盘突出症128例", 《中医学报》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102048894B (zh) | 一种治疗烧伤的中药组合物及其制备方法 | |
CN102091203A (zh) | 一种治疗难愈性创面的外用中药制剂及其制备方法 | |
CN104474471A (zh) | 一种治疗甲状腺的中药组合物 | |
CN104815295A (zh) | 一种治疗颈椎病的中药制剂 | |
CN104689066A (zh) | 一种用于治疗烧伤的中药组合物及其制备方法 | |
CN102626505B (zh) | 基于中草药的按摩膏及其制备方法 | |
CN104258151A (zh) | 一种治疗肾盂肾炎的药物及制备方法 | |
CN104524208A (zh) | 一种治疗坐骨神经痛的药物及制备方法 | |
CN104258278A (zh) | 骨伤灵喷雾剂 | |
CN102008674B (zh) | 一种治疗椎间盘突出、骨质增生和类风湿的膏药及其制备方法 | |
CN105288071A (zh) | 一种用于痔疮治疗及术后护理的中药组方及制备方法 | |
CN104771678A (zh) | 一种治疗血栓性静脉炎的药物及其制备方法 | |
CN104645122A (zh) | 一种治疗热毒浸淫型褥疮的药物及其制备方法 | |
CN104784346A (zh) | 一种治疗瘙痒症的中药洗剂制备方法 | |
CN104383384A (zh) | 一种治疗手足癣的中药洗液 | |
CN102266435A (zh) | 一种专治牛皮癣的中药 | |
CN106177639A (zh) | 一种治疗银屑病的中药组合物及其制备方法 | |
CN105250685A (zh) | 一种用于治疗烧伤的中药组合物及其制备方法 | |
CN104623304A (zh) | 一种治疗湿热毒蕴型慢性皮肤溃疡的洗剂及其制备方法 | |
CN104547384A (zh) | 一种治疗百草枯中毒的口服液及制备方法 | |
CN104758754A (zh) | 一种治疗肾气虚衰型前列腺增生的药物及制备方法 | |
CN104225259A (zh) | 一种治疗瘀热型脉管炎的中药及制备方法 | |
CN103735851A (zh) | 一种治疗骨折的中药制剂 | |
CN104083708A (zh) | 治疗肩周炎的中药软膏 | |
CN103877557B (zh) | 一种治疗甲癣的中药药膏及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150408 |
|
RJ01 | Rejection of invention patent application after publication |